HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 285/1/G235    most recent 00449.2002v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (30) Citing Articles via Google Scholar Google Scholar Articles by Salh, B. Articles by Jacobson, K. Search for Related Content PubMed PubMed Citation Articles by Salh, B. Articles by Jacobson, K.

INFLAMMATION/IMMUNITY/MEDIATORS

Curcumin attenuates DNB-induced murine colitis

¹Jack Bell Research Centre and ²Department of Pediatric Gastroenterology, Children and Women's Hospital, Vancouver, British Columbia, Canada V5Z 3P1.

Submitted 21 October 2002 ; accepted in final form 11 March 2003

Numerous therapies used for inflammatory bowel disease (IBD) target the transcription factor NF-B, which is involved in the production of cytokines and chemokines integral for inflammation. Here we show that curcumin, a component of the spice turmeric, is able to attenuate colitis in the dinitrobenzene sulfonic acid (DNB)-induced murine model of colitis. When given before the induction of colitis it reduced macroscopic damage scores and NF-B activation. This was accompanied by a reduction in myeloperoxidase activity, and using semiquantitative RT-PCR, an attenuation of the DNB-induced message for IL-1 was detected. Western blotting analysis revealed that there was a reproducible DNB-induced activation of p38 MAPK detected in intestinal lysates by using a phosphospecific antibody. This signal was significantly attenuated by curcumin. Furthermore, we show that the immunohistochemical signal is dramatically attenuated at the level of the mucosa by curcumin. We conclude that the widely used food additive curcumin is able to attenuate experimental colitis through a mechanism correlated with the inhibition of the activation of NF-B and effects a reduction in the activity of p38 MAPK. We propose that this agent may have therapeutic implications for human IBD.

inflammatory bowel disease; nuclear factor-B; p38 MAPK

This article has been cited by other articles:

				C. B. Larmonier, J. K. Uno, K.-M. Lee, T. Karrasch, D. Laubitz, R. Thurston, M. T. Midura-Kiela, F. K. Ghishan, R. B. Sartor, C. Jobin, et al. Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection Am J Physiol Gastrointest Liver Physiol, November 1, 2008; 295(5): G1079 - G1091. [Abstract] [Full Text] [PDF]

				J. O. Clarke and G. E. Mullin A Review of Complementary and Alternative Approaches to Immunomodulation Nutr Clin Pract, February 1, 2008; 23(1): 49 - 62. [Abstract] [Full Text] [PDF]

				H. Shapiro, P. Singer, Z. Halpern, and R. Bruck Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis Gut, March 1, 2007; 56(3): 426 - 436. [Full Text] [PDF]

				M. Farah, K. Parhar, M. Moussavi, S. Eivemark, and B. Salh 5,6-Dichloro-ribifuranosylbenzimidazole- and apigenin-induced sensitization of colon cancer cells to TNF-{alpha}-mediated apoptosis Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G919 - G928. [Abstract] [Full Text] [PDF]